Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_34706
http://purl.obolibrary.org/obo/CHEBI_34706
|
|---|---|
| Preferred Name | ergoloid mesylate |
| Synonyms |
Dihydroergotoxine mesilate
ergoloid methanesulfonates
dihydroergotoxine methanesulfonate
ergoloid methanesulfonate
dihydrogenated ergot alkaloids
co-dergocrine mesylate
codergocrine mesylate
Ergoloid mesylates
hydrogenated ergot alkaloids
codergocrine mesilate
C30H41N5O8S
Dihydroergotoxine mesylate
ergoloid mesylates
(2R,4R,7R)-N-[(1S,2S,4R,7S)-2-hydroxy-7-methyl-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene-4-carboxamide; methanesulfonic acid
C29H38N5O8SR
co-dergocrine methanesulfonate
dihydroergotoxine methanesulfonates
codergocrine methanesulfonate
co-dergocrine mesilate
dihydroergotoxine monomethanesulfonate
See more
See less
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | ergoloid mesylate
|
|---|---|
| label | ergoloid mesylate
|
| ATCCode | C04AE01
|
| Definition | A mixture of hydrogenated ergot alkaloids consisting of the methanesulfonic acid salts of dihydroergocornine (R = CHMe2), dihydroergocristine (R = CH2Ph), and alpha- and beta-dihydroergocryptine (R = CH2CHMe2 and CH(Me)Et, respectively). It is used for the symptomatic treatment of mild to moderate dementia in the elderly, although its value is not established.
|
| has pharmacological target | |
| inhibits | |
| type | |
| has role | |
| InChIKey | InChIKey=FQHMMOGHDWAXDI-WUQHHHCFSA-N
|
| is metabolised by | |
| blocks | |
| AHFScode | 12:16.00
|
| Synonym | Dihydroergotoxine mesilate
ergoloid methanesulfonates
dihydroergotoxine methanesulfonate
ergoloid methanesulfonate
dihydrogenated ergot alkaloids
co-dergocrine mesylate
codergocrine mesylate
Ergoloid mesylates
hydrogenated ergot alkaloids
codergocrine mesilate
C30H41N5O8S
Dihydroergotoxine mesylate
ergoloid mesylates
(2R,4R,7R)-N-[(1S,2S,4R,7S)-2-hydroxy-7-methyl-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene-4-carboxamide; methanesulfonic acid
C29H38N5O8SR
co-dergocrine methanesulfonate
dihydroergotoxine methanesulfonates
codergocrine methanesulfonate
co-dergocrine mesilate
dihydroergotoxine monomethanesulfonate
See more
See less
|
| xref |
KEGG DRUG:D02268
ChEBI:34706
Beilstein:8896265
DrugBank:DB01049
CASRN:8067-24-1
PharmGKB:PA164752439
Wikipedia:http://en.wikipedia.org/wiki/Ergoloid
National Drug Code Directory:0078-0101-05
Drugs Product Database (DPD):176176
KEGG COMPOUND:C14055
See more
See less
|
| CASRN | 8067-24-1
|
| prefixIRI | obo2:CHEBI_34706
|
| related with | |
| SMILES | CS(O)(=O)=O.[H][C@@]12CCCN1C(=O)[C@H](C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)(O[C@@]21O)C(C)C
CS(O)(=O)=O.[H][C@@]12Cc3c[nH]c4cccc(c34)[C@@]1([H])C[C@H](CN2C)C(=O)N[C@@]1(O[C@]2(O)N([C@@H](C)C(=O)N3CCC[C@@]23[H])C1=O)C(C)C
|
| may interact with |
See more
See less
|
| DBname | ergoloid mesylate
|
| InChI | InChI=1S/C29H37N5O5.CH4O3S/c1-15(2)28(27(37)34-16(3)26(36)33-10-6-9-23(33)29(34,38)39-28)31-25(35)18-11-20-19-7-5-8-21-24(19)17(13-30-21)12-22(20)32(4)14-18;1-5(2,3)4/h5,7-8,13,15-16,18,20,22-23,30,38H,6,9-12,14H2,1-4H3,(H,31,35);1H3,(H,2,3,4)/t16-,18+,20+,22+,23-,28+,29-;/m0./s1
|
| DBBrand |
dihydroergotoxine methanesulfonate
dihydroergotoxine methanesulphonate
dihydroergotoxin mesylate
circanol
redergin
co-dergocrine mesylate
deapril-st
hydergine lc
hydrogenated ergot alkaloids
dihydroergotoxine mesylate
ischelium
dihydroergotoxin mesilat
hydergin
hydergine
dihydroergotoxine mesilate
ergoloid mesylates [usan]
trigot
gerimal
dihydroergotoxin methanesulfonate
alkergot
See more
See less
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |